Form 4: NeuroPace Inc. Executive Martha Morrell Reports Stock Disposal
SEC Form 4 Filing
Martha Morrell, Chief Medical Officer of NeuroPace Inc., disposed of 1,430 shares of common stock to cover tax obligations.
Summary
- On February 27, 2025, Martha Morrell, the Chief Medical Officer of NeuroPace Inc., disposed of 1,430 shares of common stock.
- The transaction was executed at a price of $12.56 per share.
- Following the transaction, Morrell directly owns 80,563 shares of NeuroPace Inc.
- The disposal was related to covering tax obligations.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment, as it simply reports factual information.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership, but it is unlikely to be significant given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 02/27/2025 | Date of stock disposal transaction |
| 03/03/2025 | Date of signature on the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.